Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|23|4094-4102

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.23, 2013-12, pp. : 4094-4102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 618-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of type I gastric neuroendocrine tumors with somatostatin analogs

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 548-554

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytotoxic chemotherapy for pancreatic neuroendocrine tumors

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 628-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical features of pancreatic neuroendocrine tumors

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 578-585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathology diagnosis of pancreatic neuroendocrine tumors

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 586-593

John Wiley & Sons Inc

Access to resources Recommend Favorite